These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 10952326)

  • 61. Double-filtered leukoreduction as a method for risk reduction of transfusion-associated graft-versus-host disease.
    Chun S; Phan MT; Hong S; Yang J; Yoon Y; Han S; Kang J; Yazer MH; Kim J; Cho D
    PLoS One; 2020; 15(3):e0229724. PubMed ID: 32214402
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Transfusion-associated graft-versus-host disease. Increased risk when using HLA matched donors].
    Hovdenes J; Solheim BG
    Tidsskr Nor Laegeforen; 1995 May; 115(12):1499-501. PubMed ID: 7770854
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [HLA and transfusion].
    Wittmann G; Zimmermann R; Eckstein R
    Infusionsther Transfusionsmed; 1994 Jun; 21(3):207-12. PubMed ID: 7919910
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analysis of risk factors for post-transfusion graft-versus-host disease in Japan. Japanese Red Cross PT-GVHD Study Group.
    Takahashi K; Juji T; Miyamoto M; Uchida S; Akaza T; Tadokoro K; Shibata Y; Ino T; Hidano A
    Lancet; 1994 Mar; 343(8899):700-2. PubMed ID: 7907679
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transfusion-associated graft-versus-host disease: current concepts and future trends.
    Seghatchian MJ; Ala F
    Transfus Sci; 1995 Jun; 16(2):99-105. PubMed ID: 10155741
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Transfusion-associated graft-versus-host disease.
    Orlin JB; Ellis MH
    Curr Opin Hematol; 1997 Nov; 4(6):442-8. PubMed ID: 9359003
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Transfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanism.
    van der Mast BJ; Hornstra N; Ruigrok MB; Claas FH; van Rood JJ; Lagaaij EL
    Lancet; 1994 Mar; 343(8900):753-7. PubMed ID: 7907730
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The critical role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease in immunocompetent patients.
    Otsuka S; Kunieda K; Kitamura F; Misawa K; Sasaoka I; Hirose M; Kasuya S; Saji S; Noma A
    Transfusion; 1991; 31(3):260-4. PubMed ID: 2003327
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [A case of fatal graft-versus-host disease following blood transfusion in esophageal cancer documented by homozygous changes of HLA typing].
    Soeda K; Onoda S; Kozu T; Okuyama K; Koide Y; Isono K
    Nihon Geka Gakkai Zasshi; 1990 Aug; 91(8):1040-3. PubMed ID: 2233658
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Spontaneous resolution of transfusion-associated graft-versus-host disease.
    Mori S; Matsushita H; Ozaki K; Ishida A; Tokuhira M; Nakajima H; Kizaki M; Sugiura H; Kikuchi A; Handa M
    Transfusion; 1995 May; 35(5):431-5. PubMed ID: 7740616
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Irradiation of fresh whole blood for prevention of transfusion-associated graft-versus-host disease does not impair platelet function and clinical hemostasis after open heart surgery.
    Lavee J; Shinfeld A; Savion N; Thaler M; Mohr R; Goor DA
    Vox Sang; 1995; 69(2):104-9. PubMed ID: 8585189
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Transfusion-associated graft-versus-host disease guideline on gamma irradiation of blood components].
    Landi EP; de Oliveira JS
    Rev Assoc Med Bras (1992); 1999; 45(3):261-72. PubMed ID: 10513059
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Benefit of STR-based chimerism analysis to identify TA-GVHD as a cause of death: Utility of various biological specimens.
    Raina A; Chaudhary G; Dogra TD; Khandelwal D; Balayan A; Jain V; Kanga U; Seth T
    Med Sci Law; 2016 Apr; 56(2):142-6. PubMed ID: 25852093
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transfusion-associated graft-versus-host disease in a patient with Waldenstrom's macroglobulinaemia.
    Munro LR; Culligan DJ; Grant A; Johnston PW; Watson HG
    Vox Sang; 2002 Oct; 83(3):279-81. PubMed ID: 12366774
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Universal or selective irradiation: a comparison of approaches.
    Satake M; Suto Y
    Transfus Apher Sci; 2022 Apr; 61(2):103403. PubMed ID: 35283032
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transfusion-associated graft-versus-host disease and the irradiation of blood components.
    Davey RJ
    Immunol Invest; 1995; 24(1-2):431-4. PubMed ID: 7713602
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [A case report of graft-versus-host disease caused by using stored blood after aortic valve replacement].
    Hara Y; Morimoto K; Nakamura Y; Sasaki S; Kuroda H; Mori T; Tanaka K; Nishikawa K
    Kyobu Geka; 1993 May; 46(5):438-41. PubMed ID: 8492500
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intact survival with transfusion-associated graft-versus-host disease proved by human leukocyte antigen typing of lymphocytes in skin biopsy specimens.
    Hentschel R; Broecker EB; Kolde G; Frosch M; Friedrich W; Holzgreve W; Westphal E; Harms E
    J Pediatr; 1995 Jan; 126(1):61-4. PubMed ID: 7815227
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Blood transfusions and graft-vs-host disease.
    Ray TL
    Arch Dermatol; 1990 Oct; 126(10):1347-50. PubMed ID: 2221941
    [No Abstract]   [Full Text] [Related]  

  • 80. Is pathogen reduction an acceptable alternative to irradiation for risk mitigation of transfusion-associated graft versus host disease?
    Li M; Irsch J; Corash L; Benjamin RJ
    Transfus Apher Sci; 2022 Apr; 61(2):103404. PubMed ID: 35288055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.